Literature DB >> 27590613

Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model.

Veria Khosrawipour1,2, Tanja Khosrawipour3,4, Alexander Jens Peter Kern4, Aras Osma4, Burak Kabakci4, David Diaz-Carballo4, Eckart Förster5, Jürgen Zieren3, Khashayar Fakhrian6.   

Abstract

BACKGROUND: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel approach delivering intraperitoneal chemotherapy by means of a pressurized aerosol. This study was conducted to evaluate the distribution pattern of doxorubicin in the abdominal cavity after PIPAC in a postmortem swine model.
METHODS: Doxorubicin was aerosolized through a Micropump© (MIP) into the peritoneal cavity of two swines at a pressure of 12 mm Hg CO2 and 32 °C. To measure the distribution of the drug, 9 different positions within the abdominal cavity were sampled. In-tissue doxorubicin penetration was evaluated using fluorescence microscopy on frozen thin sections.
RESULTS: A maximum of drug penetration was observed in the area around the MIP. The penetration in the small intestine reached a depth of 349 ± 65 µm. Penetration depth in the right upper abdomen and left upper abdomen were 349 ± 65 and 140 µm ± 26 µm, respectively. Distant areas to the MIP showed variable penetration rates between 50 and 150 µm.
CONCLUSIONS: Doxorubicin reached all areas within the peritoneum. Highest penetration rates were measured in the area around the Micropump. Further studies are warranted to evaluate and optimize the distribution and penetration of cytotoxic agent into the tissue after PIPAC.

Entities:  

Keywords:  Ex vivo swine; Intraperitoneal chemotherapy; PIPAC; Peritoneal carcinomatosis; Whole abdominal radiation

Mesh:

Substances:

Year:  2016        PMID: 27590613     DOI: 10.1007/s00432-016-2234-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Carcinomatosis--is cure an option?

Authors:  Paul H Sugarbaker
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

Review 2.  The transport barrier in intraperitoneal therapy.

Authors:  Michael F Flessner
Journal:  Am J Physiol Renal Physiol       Date:  2005-03

3.  High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.

Authors:  Philippe Esquis; David Consolo; Guy Magnin; Philippe Pointaire; Philippe Moretto; Maria Dolores Ynsa; Jean-Luc Beltramo; Carole Drogoul; Michel Simonet; Laurent Benoit; Patrick Rat; Bruno Chauffert
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

4.  Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.

Authors:  Veria Khosrawipour; Tanja Khosrawipour; Thomas Albert Falkenstein; David Diaz-Carballo; Eckart Förster; Aras Osma; Irenäus Anton Adamietz; Jürgen Zieren; Khashayar Fakhrian
Journal:  Anticancer Res       Date:  2016-09       Impact factor: 2.480

Review 5.  Barriers to drug delivery in solid tumors.

Authors:  R K Jain
Journal:  Sci Am       Date:  1994-07       Impact factor: 2.142

6.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Authors:  R L Dedrick; C E Myers; P M Bungay; V T DeVita
Journal:  Cancer Treat Rep       Date:  1978-01

7.  Irradiation Does Not Increase the Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.

Authors:  Veria Khosrawipour; Alexander Bellendorf; Carolina Khosrawipour; Yousef Hedayat-Pour; David Diaz-Carballo; Eckart Förster; Ralph Mücke; Burak Kabakci; Irenäus Anton Adamietz; Khashayar Fakhrian
Journal:  In Vivo       Date:  2016 09-10       Impact factor: 2.155

8.  Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.

Authors:  Clemens B Tempfer; Günther A Rezniczek; Paula Ende; Wiebke Solass; Marc-André Reymond
Journal:  Anticancer Res       Date:  2015-12       Impact factor: 2.480

9.  Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.

Authors:  Giorgi Nadiradze; Urs Giger-Pabst; Juergen Zieren; Dirk Strumberg; Wiebke Solass; Marc-André Reymond
Journal:  J Gastrointest Surg       Date:  2015-10-28       Impact factor: 3.452

10.  Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model.

Authors:  Veria Khosrawipour; Urs Giger-Pabst; Tanja Khosrawipour; Yousef Hedayat Pour; David Diaz-Carballo; Eckart Förster; Hugo Böse-Ribeiro; Irenäus Anton Adamietz; Jürgen Zieren; Khashayar Fakhrian
Journal:  J Cancer       Date:  2016-05-07       Impact factor: 4.207

View more
  33 in total

Review 1.  Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.

Authors:  M Graversen; S Detlefsen; P Pfeiffer; L Lundell; M B Mortensen
Journal:  Clin Exp Metastasis       Date:  2018-04-28       Impact factor: 5.150

Review 2.  Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview.

Authors:  Miguel Alberto; Andreas Brandl; Pankaj Kumar Garg; Safak Gül-Klein; Mathias Dahlmann; Ulrike Stein; Beate Rau
Journal:  Clin Exp Metastasis       Date:  2019-02-04       Impact factor: 5.150

3.  HIPEC Methodology and Regimens: The Need for an Expert Consensus.

Authors:  Aditi Bhatt; Ignace de Hingh; Kurt Van Der Speeten; Martin Hubner; Marcello Deraco; Naoual Bakrin; Laurent Villeneuve; Shigeki Kusamura; Olivier Glehen
Journal:  Ann Surg Oncol       Date:  2021-06-17       Impact factor: 5.344

Review 4.  The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review.

Authors:  Robin J Lurvink; Kurt Van der Speeten; Koen P Rovers; Ignace H J T de Hingh
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 5.  Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative review.

Authors:  Soohyun Oh; Haerin Paik; Soo Jin Park; Eun Ji Lee; Hee Seung Kim
Journal:  Gland Surg       Date:  2021-03

6.  Rotational intraperitoneal pressurized aerosol chemotherapy in a porcine model.

Authors:  Jaehee Mun; Soo Jin Park; Hee Seung Kim
Journal:  Gland Surg       Date:  2021-03

7.  Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model.

Authors:  Alexander Bellendorf; Veria Khosrawipour; Tanja Khosrawipour; Simon Siebigteroth; Joseph Cohnen; David Diaz-Carballo; Andreas Bockisch; Jürgen Zieren; Urs Giger-Pabst
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

Review 8.  [PIPAC and HIPEC-competing or supplementary therapeutic procedures for peritoneal metastases].

Authors:  H Leebmann; P Piso
Journal:  Chirurg       Date:  2018-09       Impact factor: 0.955

9.  A new ex vivo model for optimizing distribution of therapeutic aerosols: the (inverted) bovine urinary bladder.

Authors:  Daniel Schnelle; Frank-Jürgen Weinreich; Janek Kibat; Marc A Reymond
Journal:  Pleura Peritoneum       Date:  2017-03-11

10.  Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy.

Authors:  Clarisse Eveno; Aminata Haidara; Ibrahim Ali; Cynthia Pimpie; Massoud Mirshahi; Marc Pocard
Journal:  Pleura Peritoneum       Date:  2017-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.